Document is current
Any future updates will be listed below
-
Authors
Abdel-fattah, M.
Chapple, C.
Guerrero, K.
Dixon, S.
Cotterill, N.
Ward, K.
Hashim, H.
Monga, A.
Brown, K.
Drake, M. J.
Gammie, A.
Mostafa, A.
Bladder Health, U. K.
Breeman, S.
Cooper, D.
MacLennan, G.
Norrie, J.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (15/150/05)
- License Information
-
More Information
Article History
Received: 6 November 2020
Accepted: 24 September 2021
First Online: 26 October 2021
Declarations
:
: The trial has ethical approval from the North of Scotland REC (17/NS/0018), and local NHS site R&D approvals have been obtained. Women must provide signed and dated written informed consent before undergoing any study-specific procedures. Verbal consent is obtained for the qualitative interviews.
: Not applicable as there are no identifying images or other personal or clinical details of participants presented. Informed consent materials are available from the corresponding author.
: Professor Abdel-fattah reports no competing interest for this study however he provides full and updated details of all potential competing interests for his research and clinical practice in general on his university staff page Karen Ward reports Topic expert: Urinary Incontinence and Pelvic Organ Prolapse NICE Guideline (NG123) 2016-2019, Vice Chair British Society of Urogynaecologists 2019-2021Ash Monga reports Consultant and paid speaker for Contura; Paid speaker Boston Scientific; Chair of the EUGA industry liaison committee; Advisory board Atlantic TherapeuticsAll other authors report no conflicts of interest.
